Avista Healthcare

May 6, 2019 at 4:30 PM EDT –Second Phase III Study 202 Meets Primary Endpoint; Provides Additional Evidence of Efficacy and Safety – – Long-term Phase III Study 203 Provides Additional Evidence of Safety – – Company to Host Conference Call on Tuesday, May 7th at 12pm ET with Dr. Chuck Slonim and Dr. Shane Kannarr – BRIDGEWATER, N.J., May 06, 2019 (GLOBE NEWSWIRE) — Osmotica […]

Canton, MA, March 4, 2019 – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that a new case series published in Plastic and Reconstructive Surgery – Global Open suggests PuraPly® Antimicrobial (PuraPly AM) positively […]

STOCKHOLM, Feb. 21, 2019 /PRNewswire/ — Trimb Healthcare AB (“Trimb”) has entered into an exclusive licensing agreement with Teva in Scandinavia for a portfolio of established OTC brands. The products include Flux, a market-leading brand in fluoride rinse, Decubal, a leading skincare brand for dry and sensitive skin, and other well-known OTC brands such as Fludent, Apobase, […]

Canton, MA and New York, NY, December 10, 2018 – Organogenesis Holdings Inc. (“ORGO”), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care, Surgical and Sports Medicine markets, today announced the completion of its previously announced business combination between Organogenesis Inc. and Avista Healthcare […]

Stockholm, December 7, 2018 – Trimb Healthcare (“Trimb”) has completed the acquisition of BioClin BV (“BioClin”), a leading intimate healthcare company based in Delft, Netherlands.  The BioClin portfolio includes several well-known, all-natural brands, such as Multi-Gyn, a leading intimate product line treating vaginal discomforts, and Multi-Mam, an innovative product line for breastfeeding mothers. BioClin’s brands […]

11/06/2018 – 17:25 Trimb Healthcare AB (“Trimb”) has entered into a definitive agreement with CCS Healthcare Nordic AB (“CCS”) to acquire their portfolio of skin care products in Sweden, Norway and the UK (“CCS Skincare Brands”). The portfolio includes several well-established and highly recognized brands, including CCS Swedish Formula, Indy Beauty1, Oliva, Bamse2, and exclusive […]

NEW YORK, Nov. 6, 2018 /PRNewswire/ — Avista Capital Partners (“Avista”), a leading private equity firm focused on growth-oriented healthcare businesses, and G&W Laboratories, Inc. (“G&W Labs”), today announced the signing of a definitive agreement for Avista to acquire G&W Labs’ extended topicals and dermatology business unit (“G&W Dermatology” or the “Company”). The transaction does not involve G&W […]

BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) — Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of 7,647,500 ordinary shares at a public offering price of $7.00 per share. The number of shares issued at closing reflected the exercise in full of the underwriters’ option to […]

If approved, CAM2038 will provide patients and HCPs with flexible-dose weekly and monthly options for the treatment of opioid use disorder, with the goal of improving treatment adherence and reducing the burdens associated with daily medication. Plymouth Meeting, Pa. —July 16, 2018 —Braeburn announces that the U.S. Food and Drug Administration (FDA) has assigned a […]

YARDLEY, Pa., July 02, 2018 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that the Company has been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2018 in the medium-sized company category. “We are proud of every single person on the Optinose team […]

CORAL GABLES, Fla., June 25, 2018 /PRNewswire/ — Kramer Laboratories, Inc. (“Kramer”), a marketer of over-the-counter (OTC) foot care and specialty cough products, today announced the acquisition of Nizoral® (“Nizoral”), a leading anti-dandruff shampoo brand sold in North America and Latin America, from Janssen Pharmaceutica NV (a member of the Johnson & Johnson family of companies). Kramer is a portfolio company […]

YARDLEY, Pa., June 11, 2018 (GLOBE NEWSWIRE) — OptiNose, Inc. (NASDAQ:OPTN), announced today the closing of its underwritten public offering of 5,750,000 of its common shares at a price to the public of $22.25 per common share, including 750,000 common shares sold pursuant to the underwriters’ exercise in full of their option to purchase additional common shares. The offering consists of […]